Abou-Foul, AK, Ross, E, Abou-Foul, M and George, AP (2021) Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services. The Journal of Laryngology & Otology. 1 - 6. ISSN 0022-2151

[thumbnail of cervical-lymphadenopathy-following-coronavirus-disease-2019-vaccine-clinical-characteristics-and-implications-for-head-and-neck-cancer-services.pdf] Text
cervical-lymphadenopathy-following-coronavirus-disease-2019-vaccine-clinical-characteristics-and-implications-for-head-and-neck-cancer-services.pdf - Published Version
Restricted to Repository staff only

Download (227kB)


<jats:title>Abstract</jats:title> <jats:sec id="S0022215121002462_sec_a1"> <jats:title>Objective</jats:title> <jats:p>Patients with coronavirus disease vaccine associated lymphadenopathy are increasingly being referred to healthcare services. This work is the first to report on the incidence, clinical course and imaging features of coronavirus disease vaccine associated cervical lymphadenopathy, with special emphasis on the implications for head and neck cancer services.</jats:p> </jats:sec> <jats:sec id="S0022215121002462_sec_a2" sec-type="methods"> <jats:title>Methods</jats:title> <jats:p>This was a retrospective cohort study of all patients referred to our head and neck cancer clinics between 16 December 2020 and 12 March 2021. The main outcomes measured were the proportion of patients with vaccine-associated cervical lymphadenopathy, and the clinical and imaging characteristics.</jats:p> </jats:sec> <jats:sec id="S0022215121002462_sec_a3" sec-type="results"> <jats:title>Results</jats:title> <jats:p>The incidence of vaccine-associated cervical lymphadenopathy referrals was 14.8 per cent (<jats:italic>n</jats:italic> = 13). Five patients (38.5 per cent) had abnormal-looking enlarged and rounded nodes with increased vascularity. Only seven patients (53.9 per cent) reported full resolution within an average of 3.1 ± 2.3 weeks.</jats:p> </jats:sec> <jats:sec id="S0022215121002462_sec_a4" sec-type="conclusions"> <jats:title>Conclusion</jats:title> <jats:p>Coronavirus disease vaccine associated cervical lymphadenopathy can mimic malignant lymphadenopathy and therefore might prove challenging to diagnose and manage correctly. Healthcare services may encounter a significant increase in referrals.</jats:p> </jats:sec>

Item Type: Article
Additional Information: The final version of this article and all relevant information related to it, including copyrights, can be found online at; https://www.cambridge.org/core/journals/journal-of-laryngology-and-otology/article/cervical-lymphadenopathy-following-coronavirus-disease-2019-vaccine-clinical-characteristics-and-implications-for-head-and-neck-cancer-services/EDFDC7E23E32A7246679127CDC16F441#article
Subjects: R Medicine > R Medicine (General)
R Medicine > R Medicine (General) > R735 Medical education. Medical schools. Research
R Medicine > RC Internal medicine
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Medicine and Health Sciences > School of Medicine
Depositing User: Symplectic
Date Deposited: 15 Oct 2021 14:20
Last Modified: 15 Oct 2021 14:20
URI: https://eprints.keele.ac.uk/id/eprint/10068

Actions (login required)

View Item
View Item